Login to Your Account



Other News To Note


Wednesday, February 20, 2013
• Galectin Therapeutics Inc., of Norcross, Ga., said it established a drug discovery program in collaboration with Geert-Jan Boons' lab at the University of Georgia to discover new carbohydrate molecules that can be used in the therapy of diseases where galectin proteins play a major role, including cancer and inflammatory and fibrotic disorders.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription